N@N

GLAXOSMITHKLINE PLC-SPON ADR (NYSE:GSK), Down By 5.77% ($2.58) From $44.720 After BUYINS.NET Report Predicted Weakness After Ea

^{Published on 2011-11-22 09:54:25 - WOPRAI}
 

November 22, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, October 25th 2011 stating that GLAXOSMITHKLINE PLC-SPON ADR (NYSE:GSK) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=gsk&id=203584

At the time this story was written, GLAXOSMITHKLINE PLC-SPON ADR (NYSE:GSK) is Down By 5.77% ($2.58) From $44.720 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

GLAXOSMITHKLINE PLC-SPON ADR (NYSE:GSK) - GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. Its principal pharmaceutical products in various therapeutic areas comprise respiratory, HIV, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, oncology and emesis, and vaccines and dermatologicals. The company offers prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets approximately 30 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company provides OTC medicines, including Panadol, a paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; and NicoDerm, NiQuitin CQ, Nicabate, and Nicorette for the treatment of nicotine withdrawal as an aid to quit smoking. Further, it offers oral healthcare products comprising Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes for the prevention of caries, gum disease, and bad breath; Sensodyne, a range of toothpastes and toothbrushes for the prevention of dental sensitivity; Biotene, a mouthwash and gel to treat dry mouth; and Polident, Poligrip, and Corega, a denture adhesive and cleanser to enhance comfort of fitted dentures and to clean dentures. Additionally, the company provides nutritional healthcare products consisting of Lucozade, an energy and sports drinks for energy and hydration; Horlicks, a malted, milk-based drink and food for nutrition application; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. GLAXOSMITHKLINE PLC-SPON ADR (NYSE:GSK) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net